| Health Care Providers & Services Industry | Healthcare Sector | - CEO | KRX SM Exchange | - ISIN |
| KR Country | - Employees | - Last Dividend | - Last Split | - IPO Date |
Inventage Lab Inc. is a pioneering company specializing in the development of cutting-edge medicines. Founded in 2015 and located in Seongnam-si, South Korea, this platform technology firm stands at the forefront of integrating microfluidics into drug delivery systems. This innovative approach aims at transforming the pharmaceutical landscape by offering more efficient and targeted therapeutic solutions. As a company, Inventage Lab Inc. leverages the potential of microfluidic technology to tackle the challenges in drug delivery, ensuring medications are delivered in the most effective way possible.
At the core of Inventage Lab Inc.'s offerings are their microfluidics based drug delivery systems. These systems utilize the principles of microfluidics to manipulate small fluids, enabling the precise control and delivery of drugs to targeted areas in the body. This technology fosters the development of advanced therapeutic products with the potential for greater efficacy and minimized side effects compared to traditional delivery methods.